Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
about
Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and DiseaseMolecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceEndocrine FGFs: Evolution, Physiology, Pathophysiology, and PharmacotherapyRegulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth FactorsThe Fibroblast Growth Factor signaling pathwaySteroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation.FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patientsEngineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.β1-Integrin Deletion From the Lens Activates Cellular Stress Responses Leading to Apoptosis and FibrosisEmerging roles of FGF signaling in hepatocellular carcinoma.Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma.Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model.
P2860
Q26752330-6FEF47E1-6E79-40A2-80FA-BEF75DFA26C5Q26769609-2CC5915E-F08D-4C5C-AA63-C7C9E02059D2Q26781556-9B52F42F-CCFC-4DD1-96B9-6950496550CFQ28076863-3CB32A69-9CC0-48E1-8464-60FC4F18C69EQ34467171-AE7C8E81-3D13-47AC-873C-311E9C8251A7Q35883853-275CB9F2-AC2E-4913-92CE-FAD629B7F485Q36274229-1291EB35-4C9A-4CC4-94D6-E15128CA0248Q37046398-031E84C1-C1FA-405A-A110-F2C8F47EB222Q37094042-DD113488-7115-4A26-B323-48D1D6555D71Q37337378-BD03474F-7A5B-494A-AB12-C4694A7709DDQ37538343-5C14C632-788D-4167-8B84-A0D8E749441EQ37584099-54CD2EEB-5063-4E23-AADA-6A97595559BFQ37588455-490F4D00-1350-4DE9-9740-30DFF82C9944Q38633258-E18221C2-5D45-429F-869B-0C89B08D6631Q38695596-96C2E0D3-E87E-4673-AD94-39D2C75E4FB9Q41207747-7EE31E0F-9492-41F7-B6A7-DDF5B064FDF6Q41876265-3E1560FF-1C37-464D-AA6F-47E2BA251B7BQ42343453-EDD42559-BF67-4058-A51E-7EBF87E13F1DQ51138526-CCD7C9D8-FF68-44C1-A827-46537254876E
P2860
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
@en
type
label
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
@en
prefLabel
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
@en
P2093
P2860
P50
P356
P1476
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
@en
P2093
Fernando J Corrales
Maite G Fernandez-Barrena
Raquel Urtasun
P2860
P304
P356
10.1002/IJC.29287
P50
P577
2014-11-06T00:00:00Z